3 Drug Discovery Trends We’re Watching in 2025
The ebook highlights three key drug discovery trends for 2025: the impactful use of AI in predictive modeling and data integration, the rise of multimodal discovery platforms like Geneious Luma that unify research across therapeutic modalities, and the Lab-in-a-Loop approach that leverages AI-driven integration of R&D and clinical data to accelerate and optimize drug development.
Stay Ahead in the Fast-Evolving World of Drug Discovery
As the life sciences landscape transforms, staying informed on the latest trends is essential for researchers and innovators. This ebook explores the key shifts reshaping the industry, from the rise of AI to the adoption of multimodal discovery platforms and the emergence of Lab-in-a-Loop methodologies.
What’s Inside:
-
AI at the Tipping Point: Learn how AI is driving tangible outcomes in drug discovery, from predictive models for multispecific antibodies to advanced composite AI capabilities that integrate diverse data sources for breakthrough insights.
-
The Multimodal Future: Discover why multimodal discovery is becoming a reality and how unified platforms like Geneious Luma enable seamless research across therapeutic modalities, empowering teams to innovate faster and more effectively.
-
Lab-in-a-Loop Efficiency: Explore how integrating R&D and clinical data through AI-powered cycles can predict and refine experiments, accelerating drug discovery timelines and optimizing resources.
Why Download?
Gain valuable insights into the cutting-edge strategies and technologies transforming drug discovery. Whether you’re navigating the challenges of big data, exploring new therapeutic modalities, or looking to optimize your R&D efficiency, this eBook offers practical guidance to keep you at the forefront of innovation.
Download the ebook to uncover the trends and tools that will shape the future of drug discovery in 2025 and beyond!
Related
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
3 Customer Trends We’re Watching in 2025
In 2025, life science teams are prioritizing three key trends—Lab-in-a-Loop platforms that integrate instruments, data, workflows, and models to boost R&D efficiency; true multimodal discovery enabled by flexible informatics supporting diverse data types without fragmented tools; and Composite AI leveraging layered, governed, and traceable data across disciplines—all aimed at delivering tangible scientific innovation while addressing resource constraints and stringent AI governance requirements.
Reasonable Expectations, Clean Data, Collaboration: The Three Keys to AI in Drug Discovery
The article explains that while AI and machine learning have long been used in drug discovery, recent hype and massive investments have led to unrealistic expectations, emphasizing that success depends on setting reasonable goals, ensuring clean and abundant data, and fostering collaboration, as most AI-driven drug candidates remain in early development stages and face complex biological and practical challenges.
NBC Louisiana: How AI is Accelerating Drug Discovery
In an NBC Louisiana feature, Dotmatics’ VP Phil Mounteney explained how AI is revolutionizing drug discovery by significantly reducing development time from up to ten years to potentially half, enhancing efficiency in analyzing vast data sets while ensuring data privacy by keeping sensitive information secure and in-house.
Gray TV Washington DC: AI helping scientists make drug breakthroughs
The Gray TV Washington DC feature highlights how scientists, including Christian Olsen of Dotmatics, are leveraging AI and machine learning to accelerate drug discovery and expedite bringing new drugs to market.
U.S. News & World Report: How AI is Transforming Medicine and Patient Care
A U.S. News & World Report article highlights how AI-driven platforms like Dotmatics Luma are revolutionizing healthcare and life sciences by enabling scientists to efficiently manage large datasets, accelerate drug discovery, and enhance patient care through real-time data integration and decision-making.